Understanding short-term suicide risk in adolescents
Neurocognitive characteristics of short-term risk for suicidal behavior in adolescents
This study is looking at how certain thinking patterns in teenagers can help us understand when they might be at a higher risk for suicidal thoughts or actions, so we can better support them during those vulnerable times.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Massachusetts General Hospital NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-10459432 on NIH RePORTER |
What this research studies
This research investigates the neurocognitive factors that may indicate short-term risk for suicidal behavior in adolescents. By focusing on short-term risk rather than long-term predictors, the study aims to identify when young individuals are most vulnerable to suicidal thoughts and actions. Utilizing advanced computational psychiatry methods, the research will analyze multiple cognitive processes simultaneously to create more accurate predictions of suicidal behavior. This approach seeks to fill a critical gap in existing suicide prevention strategies by providing timely insights into adolescent mental health.
Who could benefit from this research
Good fit: Ideal candidates for this research are adolescents aged 12 to 21 who may be experiencing suicidal thoughts or behaviors.
Not a fit: Patients outside the age range of 12 to 21 or those not experiencing any suicidal ideation may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved identification and intervention strategies for adolescents at immediate risk of suicide.
How similar studies have performed: While there has been significant research on long-term suicide risk, this focus on short-term neurocognitive predictors is relatively novel and has not been extensively tested.
Where this research is happening
Boston, United States
- Massachusetts General Hospital — Boston, United States (Active)
Researchers
- Principal investigator: Liu, Richard T — Massachusetts General Hospital
- Study coordinator: Liu, Richard T
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.